Current tests are not sensitive enough to detect low levels of viral bugs or are limited to detecting only those viruses suspected of being responsible for a patient's illness.
"With this test, you don't have to know what you're looking for," said senior author Gregory Storch, professor at the Washington University School of Medicine.
"It casts a broad net and can efficiently detect viruses that are present at very low levels," Storch said.
The study demonstrates that in patient samples the new test - called ViroCap - can detect viruses not found by standard testing based on genome sequencing.
Developed in collaboration with the university's McDonnell Genome Institute, the test sequences and detects viruses in patient samples and is just as sensitive as the gold-standard polymerase chain reaction (PCR) assays, which are used widely in clinical laboratories.
However, even the most expansive PCR assays can only screen for up to about 20 similar viruses at the same time.
The researchers evaluated the new test in two sets of biological samples - for example, from blood, stool and nasal secretions - from patients at St Louis Children's Hospital.
Standard testing failed to detect common, everyday viruses - influenza B, a cause of seasonal flu; parechovirus, a mild gastrointestinal and respiratory virus; herpes virus 1, responsible for cold sores in the mouth; and varicella-zoster virus, which causes chickenpox.
In a second group of children with unexplained fevers, standard testing had detected 11 viruses in the eight children evaluated.
But the new test found another seven, including a respiratory virus called human adenovirus B type 3A, which usually is harmless but can cause severe infections in some patients.
"The test is so sensitive that it also detects variant strains of viruses that are closely related genetically," said corresponding author Todd Wylie, an instructor of pediatrics.
The study was published in the journal Genome Research.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
